Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin

TerminatedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

July 5, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Pulmonary Arterial Hypertension
Interventions
COMBINATION_PRODUCT

Remunity Pump for Remodulin

Participants on the study will receive Remodulin via the Remunity Pump with dosing and titration managed at the discretion of the prescribing healthcare professional. Dosing and titration of Remodulin will in no way be influenced by the participation in this study or this protocol.

Trial Locations (1)

27560

Syneos Health, Morrisville

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY